Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Verapamil recommended for first-line treatment of cluster headache

Oct. 19, 1998

40th PDR Annual General Meeting

Oct. 19, 1998

Anti-IgE antibody in the treatment of asthma: an interesting theory is validated

Oct. 8, 1998

Genotyping accurately predicts response to treatment with 5-LO inhibitor

Oct. 8, 1998

Radiolabeled peptide from Diatide effectively pinpoints site of infection

Oct. 8, 1998

Use of rPAF-AH in necrotizing colitis, ARDS and acute pancreatitis

Oct. 8, 1998

PAF antagonists in the treatment of asthma: promise or hype?

Oct. 8, 1998

rPAF-AH shows neuroprotective activity in hippocampal neurons

Oct. 7, 1998

Chalcone derivatives show potential in the treatment of leishmaniasis

Oct. 7, 1998

Gatifloxacin highlighted at ICAAC as an effective new treatment for pneumonia

Oct. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...